Condition: Multiple Sclerosis · NMO Spectrum Disorder · Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease · Sponsor: icometrix
The RECLAIM study aims to gather a centralized and harmonized dataset, enabling the secondary use of data for building AI-based models that will support diagnosis and prognosis of individual Multiple Sclerosis patient's disease course and treatment response in a real-world setting. Additionally, the data will be used to generate further insights on Multiple Sclerosis progression as well as to develop the tools to monitor this progression.
This description comes directly from the study's public registry record.
Diana M Sima, PhD · +32 16 369 000 · diana.sima@icometrix.com
Vincenzo Anania · +32 16 369 000 · vincenzo.anania@icometrix.com
Always discuss trial participation with your own doctor first.
| General University Hospital Prague | Prague, Praha 2, Czechia | Recruiting |
| Katholisches Klinikum Bochum - St. Joseph-Hospital | Bochum, Bochum, Germany | Recruiting |
| ERC Charité - Universitätsmedizin Berlin | Berlin, State of Berlin, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06280755